Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas
This review covers the literature between 1989 and 2007 on studies relevant to the neuro-oncology usage of eflornithine (α-difluoromethylornithine), an oral agent that irreversibly inhibits the enzyme ornithine decarboxylase. It covers the use of eflornithine, alone or in combination, to treat high-...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis Group
2018-04-01
|
| Serija: | CNS Oncology |
| Teme: | |
| Online dostop: | https://www.futuremedicine.com/doi/10.2217/cns-2017-0031 |
| Oznake: |
Brez oznak, prvi označite!
|